Overview of Immunotherapy Administration for Miller Fisher Syndrome in Japan: A Nationwide Retrospective Cohort Study
Our findings highlight the widespread use of immunotherapies for MFS in Japan despite its generally favorable natural course.
Authors
- Mitsuhiro Kainaga (ORCID: https://orcid.org/0000-0002-6196-5901)
- Masashi Hamada (ORCID: https://orcid.org/0000-0002-2866-8067)
- Yohei Hashimoto (ORCID: https://orcid.org/0000-0002-7944-6923)
- Taeho Jo (ORCID: https://orcid.org/0000-0001-7448-9433)
- Shotaro Aso (ORCID: https://orcid.org/0000-0002-7804-2433)
- Satoshi Kodama (ORCID: https://orcid.org/0000-0002-0576-1859)
- Yuichiro Shirota
- Hideo Yasunaga
- Hiroki Matsui (ORCID: https://orcid.org/0000-0002-9605-442X)
- Kiyohide Fushimi (ORCID: https://orcid.org/0000-0002-1894-0290)
- Tatsushi Toda
Institutions
- The University of Sydney (AU)
- University of Iowa Hospitals and Clinics (US)
- The University of Tokyo (JP)
Publication Details
- Journal
- Annals of Clinical Epidemiology
- Published
- 2025-06-19
- DOI
- https://doi.org/10.37737/ace.26002
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00